Breast Ultrasound Course (Aug 16 - 18, 2024)
Breast Ultrasound Course is organized by Medical Technology Management Institute (MTMI) and will be held from Aug 16 - 18, 2024.
Description:
New! More Scanning Time and enhanced 3-day schedule. This course provides increased knowledge of the technical and clinical aspects of breast ultrasound as well as practical hands-on training in ultrasound imaging of the breast. An overview of the basic principles and techniques utilized in breast ultrasound are presented. This course is helpful for mammographers and sonographers who are directly involved in breast sonography and imaging and physicians whose practice includes women’s health.
Our in-person and online ultrasound courses utilize a combination of lecture sessions and positioning workshops taught by an experienced sonographer and technologist. Instruction in patient scanning is stressed with hands-on demonstrations using clinical ultrasound scanners, tissue equivalent breast phantoms and live models. (Hands-on sessions are for attendees of in-person ultrasound courses only)
Educational Objectives:
At the completion of this course, participants will be able to:
• Optimize preparation for ARRT and ARDMS Breast Ultrasound Registry exams.
• Understand how the basic principles and instrumentation of ultrasound affect the technique of breast ultrasound.
• Recognize normal breast anatomy on the ultrasound image and evaluate lesions for their benign or malignant features.
• Recall the mammographic and ultrasonic features of specific benign and malignant lesions.
• Explain the role and importance of mammography, ultrasound, MRI, nuclear medicine, and ductography in the work up and management of the breast.
• Recognize breast ultrasound artifacts, understand why they occur, and describe techniques to minimize the occurrence of those that degrade the image.
• Develop an awareness of the invasive procedures that are available, as well as the benefits and limitations of each.
• Define the different surgical and nonsurgical treatment options for patients who develop breast cancer.
